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Evaluation of energy metabolism 
and calcium homeostasis in cells 
affected by Shwachman-Diamond 
syndrome
Silvia Ravera1, Carlo Dufour2, Simone Cesaro3, Roberta Bottega10, Michela Faleschini4, 
Paola Cuccarolo5, Fabio Corsolini6, Cesare Usai7, Marta Columbaro8, Marco Cipolli9, 
Anna Savoia4,10, Paolo Degan5 & Enrico Cappelli2
Isomorphic mutation of the SBDS gene causes Shwachman-Diamond syndrome (SDS). SDS is a rare 
genetic bone marrow failure and cancer predisposition syndrome. SDS cells have ribosome biogenesis 
and their protein synthesis altered, which are two high-energy consuming cellular processes. The 
reported changes in reactive oxygen species production, endoplasmic reticulum stress response and 
reduced mitochondrial functionality suggest an energy production defect in SDS cells. In our work, we 
have demonstrated that SDS cells display a Complex IV activity impairment, which causes an oxidative 
phosphorylation metabolism defect, with a consequent decrease in ATP production. These data were 
confirmed by an increased glycolytic rate, which compensated for the energetic stress. Moreover, the 
signalling pathways involved in glycolysis activation also appeared more activated; i.e. we reported 
AMP-activated protein kinase hyper-phosphorylation. Notably, we also observed an increase in a 
mammalian target of rapamycin phosphorylation and high intracellular calcium concentration levels 
([Ca2+]i), which probably represent new biochemical equilibrium modulation in SDS cells. Finally, 
the SDS cell response to leucine (Leu) was investigated, suggesting its possible use as a therapeutic 
adjuvant to be tested in clinical trials.
Shwachman–Diamond syndrome (SDS) is an autosomal recessive disease characterized by pancreatic insuffi-
ciency, skeletal abnormalities, bone marrow failure and predispositions to myelodysplastic syndrome (MDS) 
and acute myeloid leukaemia (AML)1,2. SDS is caused by mutations in the SBDS (Shwachman-Bodian-Diamond 
syndrome) gene, which account for approximately 90% of affected individuals3. Consistent with the hypothesis 
that at least one SBDS variant is hypomorphic, knock-out Sbds− /− mice are embryonic lethal4.
The SBDS protein localizes in the nucleolus where it plays an important role in ribosome biogenesis, as was 
shown in several studies5–7. SBDS is also involved in other molecular processes that may be independent of 
ribosome biogenesis, such as chemotaxis8, mitotic spindle formation9 and cellular stress responses. Regarding 
the latter aspect, in SBDS depleted human cells, endoplasmic reticulum (ER) stress is associated with caspase 
3 cleavage and activation of the intrinsic apoptotic pathway, as well as eukaryotic initiation factor 2-alpha 
(eIF2-alpha) phosphorylation, which rapidly reduces mRNA translation initiation10. Finally, the silencing of the 
SBDS gene in human cells and a yeast model depleted of its SBDS orthologue (Sdo1) display reduced mitochon-
drial functionality11. In turn, ER and mitochondrial stress may induce reactive oxygen species (ROS) production 
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leading to increased apoptosis and decreased cell growth12. Ribosome biogenesis and mRNA translation are high 
energy-demanding processes.
The aim of this study was to characterize the energetic and respiratory profiles and the biochemical pathways 
that may modulate these processes in SDS cells.
Results
Energetic metabolism is defective in SDS cells. Bone marrow failure with leukaemic evolution is a 
clinical feature not only of SDS but also of other inherited marrow failure diseases, such as Fanconi anaemia. As 
Fanconi anaemia cells have defective energetic metabolism because of reduced respiration and ATP production 
rates13–15 and as ribosome biogenesis and mRNA translation require high amounts of energy, we investigated 
energetic metabolism in SDS cells.
First, we measured the intracellular concentrations of ATP and AMP as expressed by the ATP/AMP ratio. 
As reported in Fig. 1A, the ATP/AMP ratio was significantly lower in the SDS cells than in the controls, both in 
primary lymphocytes (LYC) and in lymphoblast (LB) cell lines. In particular, we observed a reduction in ATP 
and an accumulation of AMP concentrations, suggesting a strong deficit in energy production (Fig. 1B). Indeed, 
expression of the wild-type (wt) form of SBDS in mutant lymphoblast cells restored the ATP/AMP ratio, suggest-
ing a role for SBDS protein in energy production (Fig. 1B).
The principal source of cellular ATP is oxidative phosphorylation (OXPHOS). This system produces energy 
by oxygen consumption only when the respiratory complex activity is coupled with functioning FoF1 ATP syn-
thase16. By contrast, in uncoupled conditions, where the respiring complexes are uncoupled from ATP synthase, 
oxygen consumption is not associated with the ATP production, which can induce oxidative stress17. To evalu-
ate oxidative metabolism, we then measured oxygen consumption after stimulation of the respiratory pathways 
using pyruvate/malate or succinate, which are substrates linked to the activity of complexes I, III and IV and 
complexes II, III and IV, respectively. In control cells, the two substrates induced increased oxygen consumption 
(Fig. 1C), while in the SDS cells, oxygen consumption was significantly lower and the decrease was more evident 
with the pyruvate/malate substrate (Fig. 1D). These findings were consistent with a lower ATP/AMP ratio and 
indicate that in SBDS cells, OXPHOS activity is impaired. Similar to the ATP/AMP ratio, oxygen consumption 
was restored to normal in complemented SDS cells (Fig. 1E), which further supported the involvement of SBDS 
protein in energy metabolism and mitochondrial function.
Considering that the defective respiratory pathways share complexes III and IV, we hypothesized that the 
activity of one of the two complexes was impaired in SDS. Although complex III activity was similar to the control 
(Supplementary Figure 2C), complex IV activity was dramatically lower in the SDS cells (Fig. 1G), while it was 
restored to normal in the complemented SDS cells. In support of this finding, complex I and II activities were in 
the normal range (Supplementary Figure 2A,B) in the control cells.
Complex IV is made up of 32 proteins that are encoded by nuclear or mitochondrial DNA. To investigate if 
complex IV deficiency was due to reduced expression of these proteins, we chose to assess the expression levels 
of two components of complex IV, COX5A and COX2, which are codified by nuclear and mitochondrial DNA, 
respectively. As shown in Fig. 1H, COX5A and COX2 were expressed at normal levels in the SDS cells, which sug-
gests that a functional deficiency of complex IV did not seem to be due to defective protein expression. Moreover, 
the restoration to normal complex IV function observed after complementation of the SDS cells suggests that this 
defect was related to faulty SBDS proteins.
In order to test which alternative energetic pathways might support ATP production, we investigated glyc-
olysis, which represents the most common alternative energy source with respect to OXPHOS. As reported in 
Fig. 2A, we found that the lactate concentration, a marker of the glycolytic flux in the culture medium, was signif-
icantly higher in the SDS cells than in both the controls and the corrected SDS cells, confirming that the glycolysis 
pathway sustained the energy demand of the SDS cells.
This group of experiments demonstrates that SDS cells have increased energetic stress due to a reduced respi-
ration ability that is caused by impaired complex IV activity and that energy supply is provided by the activation 
of the alternative glycolytic pathway. In particular, these defects were related to the mutated SBDS protein, as they 
were restored after complementation of cell lines with SBDS gene.
Reduced oxidative phosphorylation increases ROS and malondialdehyde (MDA) production in 
SDS cells. A functional deficiency in OXPHOS activity is associated with increased oxidative stress products, 
which are increased in SBDS-silenced cells18. Both the lymphocytes and lymphoblast cell lines from SDS indi-
viduals had similar ATP and AMP levels as well as oxymetric parameters; therefore, in order to assess oxidative 
stress, we measured ROS by cytometry after staining cells with H2DCFH-DA under baseline conditions and after 
exposure to 100 μ M H2O2 in the lymphoblast cells lines only. As expected, the H2O2 exposed SDS cells gener-
ated more ROS than controls. Although the baseline fluorescence (fluorescence arbitrary units) was only slightly 
increased in the SDS cells (4.2 ± 3.1) compared with the wt cells (3.4 ± 1.2), this finding was significantly higher 
(18.7 ± 9.4 vs 7.1 ± 2.5; p > 0.05) after H2O2 induction, thus pointing to excessive ROS production in the SDS 
cells under stress conditions only.
ROS attacks polyunsaturated fatty acid membranes, generating lipid peroxides19,20. As a biomarker of the lipid 
peroxidation process, we measured malondialdehyde, a breakdown product of lipid peroxides21. As shown in 
Fig. 2B, the MDA level was higher in the SDS cells than in the control samples (p < 0.001), thus confirming the 
existence of lipid peroxidation in these cells consequent to the increased oxidative stress levels.
Nevertheless, when we assessed mitochondrial morphology by electron microscopy, we did not find any rele-
vant differences between the SDS and control cells (Supplementary Figure 3).
In conclusion, these experiments show that the SDS cells, probably in relationship with dysfunctional 
OXPHOS, do produce excessive ROS mainly under stressed conditions. This in turn caused lipid membrane 
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Figure 1. Energetic metabolism is defective in SDS cells. (A) The AMP/ATP ratio was calculated using 
data from the table in (B) (*P < 0.001). (B) The ATP and AMP contents measured in lymphoblasts (LB) 
and lymphocytes (LYC) of wt, SDS and their isogenically corrected counterparts (SDS-corr) cells. The AMP 
and ATP assays routinely employed cell homogenates from 100 to 200,000 cells. The data are expressed 
as means ± SD of at least 3 different experiments. Panels (C–E) show the oxygen consumption in wt, SDS 
and SDS-corr cells measured with an amperometric electrode, respectively. Panel (F) shows the number of 
samples examined and the oxygen consumption values (μ M O2/min/mg) at the level of complex I (pyruvate/
malate) or complex II (succinate) of oxidative phosphorylation. The data are expressed as means ± SD of 
at least 3 different experiments. Two-hundred and fifty to 500,000 cells were routinely analysed for each 
oxymetric titration. (G) The complex IV (cytochrome c oxidase) activity was measured following oxidation 
of ascorbate-reduced cytochrome C at 550 nm. The data were obtained from the medians of at least 3 different 
experiments. *p < 0.001. (H) Western blots of COX5A and COX2, which are complex IV components of 
nuclear and mitochondrial DNA origin, respectively. SDS and wt lymphoblast and lymphocyte extracts showed 
comparable levels of both proteins, as demonstrated by the densitometric analysis reported in the table (the 
data are reported as the relative optical density normalized to the actin signal). Legend: LB (lymphoblasts), 
LYC (lymphocytes), SDS (Shwachman-Diamond syndrome), wt (wild type), SDS-corr (Shwachman-Diamond 
syndrome transfected with SBDS gene), SDS-mock (Shwachman-Diamond syndrome transfected with empty 
vector).
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peroxidation that, however, did not alter mitochondrial morphology. Overall, these results seem to suggest 
the presence of increased oxidative stress in SDS cells, which was unable to severely impair the mitochondrial 
structure.
Energetic stress response pathway. In order to test which compensatory mechanisms SDS cells utilize 
to counteract defective energy production (energetic stress), we assessed AMP-activated protein kinase (AMPK) 
and the PI3K/AKT/mammalian target of rapamycin (mTOR) pathway, which are the main regulatory mecha-
nisms activated by energy deficiency.
Under stress conditions AMPK, which is activated by AMP accumulation, antagonizes mTOR and stimulates 
alternative catabolic processes, such as glycolysis, which works to counteract the energy constraint. The PI3K/
AKT/mTOR pathway induces cell proliferation through mitochondria and ribosome biogenesis. AKT that is 
phosphorylated on Thr803 by PI3K (phosphatidylinositol 3-kinase) inhibits AMPK and induces mTOR acti-
vation. mTOR in turn regulates AKT phosphorylation at Ser473, which is a site required for its maximal acti-
vation22–26. Therefore, in wild type cells, when AMPK is activated, the PI3K/AKT/mTOR pathway is normally 
inhibited.
In SDS cells, as expected, AMPK is more active than in controls, as shown by Western blot analysis of the 
phosphorylated form of the protein (Fig. 3). Surprisingly, we found that mTOR was not inhibited and instead it 
was highly phosphorylated compared with the normal and corrected controls.
Consistent with this finding, we documented that AKT was also hyper-phosphorylated at Thr803 and Ser473 
in the SDS cells in comparison with wild type and corrected cells, thus confirming the hyper-activation of the 
whole PI3K/AKT/mTOR pathway.
In conclusion, these experiments show that SDS cells respond aberrantly to energetic stress and this response 
was related to the SDS protein, as PI3K/AKT/mTOR pathway hyper-activation was not seen in the corrected cells.
SDS cells have high cytoplasmic calcium concentration levels. Ca2+ regulates eukaryotic protein 
translation27 and many other cellular ATP-consuming reactions; thus, it is a crucial protein synthesis and energy 
metabolism signalling molecule. Moreover, high [Ca2+]i is strongly associated with ROS cytotoxicity, lipid perox-
idation and OXPHOS functionality, and it inhibits complex IV activity28–30.
In resting conditions, the [Ca2+]i was twofold (133 ± 8 nM) higher in SDS cells than in wild type (65 ± 2 nM) 
or corrected (64 ± 1 nM) cells (Table 1).
To investigate the cause of the increased [Ca2+]i, we assessed the ability of the ER to capture calcium from the 
cytoplasm and store it. Indeed, the ER is the main intracellular calcium storage site and plays an important role in 
Ca2+ homeostasis through the SERCA (calcium ATP-ase channel) activity, which transfers Ca2+ from the cytosol 
Figure 2. SDS cells have increased glycolysis and oxidative stress. (A) Extracellular lactate production is 
a marker for the glycolysis pathway. Lactate production was higher in the SDS lymphocyte and lymphoblast 
medium, suggesting an increase in the glycolysis pathway to sustain the energy request. The data are the 
medians of at least 3 different experiments. #P < 0.005. (B) Malondialdehyde (MDA), a lipid peroxidation 
product, was utilized as a marker of oxidative stress. The MDA level was significantly increased in SDS cells 
compared with wt cells. The data are the medians of at least 3 different experiments. *p < 0.001. Legend: 
LB (lymphoblasts), LYC (lymphocytes), SDS (Shwachman-Diamond syndrome), wt (wild type), SDS-corr 
(Shwachman-Diamond syndrome cells transfected with the SBDS gene), SDS MOCK (Shwachman-Diamond 
syndrome cells transfected with empty vector).
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to the ER31. Thapsigargin (TG) irreversibly blocks the SERCA channels, causing Ca2+ to escape from the ER and 
consequently increase the [Ca2+]i32. Treatment with high TG doses (3 μ M) induced a significant [Ca2+]i increase 
in wild-type and corrected cells compared with the SDS cells, thus suggesting an impaired ability of these cells to 
store Ca2+ in the ER, which may account for the increased [Ca2+]i (Table 1).
Even though we did not find any SERCA channel activity differences (data not shown), we speculate that the 
increased [Ca2+]i may depend on the mTOR activation that we observed in the SDS cells, which is known to pos-
itively regulate calcium release via the inositol-1,4,5 triphosphate receptor33.
Leucine restores the normal metabolic phenotype. Since leucine (Leu) is an essential amino acid 
known to promote proteins synthesis, even in SBDS-deficient cells18, we tested the biochemical effect of Leu on 
SDS lymphocytes and lymphoblast cells after 5 days of treatment. After Leu treatment, the complex IV function-
ality was restored, resulting in a respiration rate and an ATP/AMP ratio that was comparable with the controls 
(Fig. 4A–D) along with a reduced intracellular calcium concentration (Fig. 4G). The phenotypic reversion was 
also associated with a reduction in lipid peroxidation and lactate production (Fig. 4E,F). Surprisingly, treatment 
with N-acetyl cysteine (NAC), an antioxidant molecule that is a precursor of reduced glutathione, showed no or 
poor recovery of the respiratory defect, energetic distress and altered calcium homeostasis that was observed in 
the SDS cells (data not shown).
We then tested the effect of Leu on marrow haematopoietic progenitor cell growth from patients with SDS, 
and observed a moderate increase in erythroid but not myeloid colony growth (Fig. 5A). Since Leu is a modu-
lator of mTOR activation34, we studied its effects on the energetic stress pathway after chronic SDS cell treat-
ment. As expected, the reduction in AMPK phosphorylation was a consequence of the restoration of normal 
OXPHOS. Interestingly, the AKT and mTOR phosphorylation levels were also reduced following the Leu treat-
ment (Fig. 5B). It may be speculated that these effects were due to feedback regulation of the AKT/mTOR pathway 
Figure 3. An aberrant energetic stress pathway response in SDS cells. (A) Western blot of the phosphorylated 
forms of AMPK, mTOR and AKT (Thr803 and Ser473), which showed increased activation in SDS cells. Genetic 
correction with the SBDS gene restored normal phosphorylation levels of these proteins. (B) Densitometric 
analysis of the WB signals. The data are expressed as relative optical densities.
Basal (untreat cells) Thapsigargin
LB wt 65 ± 2 509 ± 29
LB SDS 133 ± 8 177 ± 31
LB SDS Corr. 64 ± 1 510 ± 26
LB SDS Mock 121 ± 6 178 ± 30
Table 1.  [Ca2+]i measured in baseline condition and after treatment with thapsigargin in WT, SDS and 
SDS corrected or mock lymphoblasts. Calcium concentration is expressed as nanomolar (nM). Data expressed 
as mean ± SD of at least 3 different experiments.
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that is dependent on nutrient excess35. Finally, as Leu restored the biochemical phenotype in the SDS cells, this 
molecule could be regarded as a potential tool to restore energetic metabolism in SDS cells.
Discussion
SDS is a ribosomopathy that results from mutations affecting the expression/function of the SBDS protein, which 
plays a role in ribosome biogenesis and protein synthesis, two highly energy consuming processes that are finely 
coordinated with cellular energy production. Cellular respiration is a set of metabolic reactions and processes 
that converts nutrients into biochemical energy, chiefly ATP. This process is carried out by a series of protein 
complexes called electron transport chains that are localized in the mitochondrial inner membrane and connect 
to the mitochondrial intermembrane space and matrix. Impaired respiration undermines ATP production and 
exposes the cell to energetic and oxidative stress17.
In this study, we evaluate energetic metabolism in SDS cells and found that oxygen consumption was impaired 
when it was induced by pyruvate/malate or succinate. Consequently, ATP production was reduced and AMP 
accumulated, which altered the ATP/AMP ratio.
Electrons are transported through two pathways. The first, which is composed of complexes I, III and IV, 
transports electrons from NADH and is pyruvate/malate inducible. The other requires complexes II, III and IV 
Figure 4. Treatment with leucine induce recovery of the respiration rate and energetic stress. ATP/AMP 
ratio (A) in SDS lymphoblast and lymphocytes was comparable to the wt cells after leucine treatment as well as 
ATP and AMP levels (B) respiration rate (C), complex IV activity (D), extracellular lactate concentration  
(E) MDA lipid peroxidation (F) and [Ca2+]i (G).
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and is activated by succinate, whereby it transfers the electrons from FADH2 and is less efficient in energy produc-
tion than the first pathway. As both pyruvate/malate and succinate affect oxygen consumption to the same extent 
in SDS cells, we investigated the activity of the two complexes (III and IV) that are shared by the two pathways, 
and we demonstrated that complex IV did not work properly.
The causes of the complex IV activity impairment are not clear. The expression levels of COX5A and COX2, 
two subunits of complex IV that are encoded by nuclear and mitochondrial genes, respectively, were evaluated, 
and we observed that these two proteins were expressed at normal levels. This suggests that their synthesis was 
not impaired despite the ribosome biogenesis and transduction defects in the SDS cells. However, it is important 
to note that complex IV is composed of 32 proteins, 3 of which are encoded by mitochondrial DNA and 29 are 
encoded by nuclear DNA. Additionally, 11 are structural and 18 are assembling factors36,37; therefore, we cannot 
exclude that one of the other subunits was less expressed or not correctly folded.
Another cause may be represented by an alteration in the mitochondrial membrane, which is determined by 
altered electron transfer amongst complexes III and IV, or among complex IV and oxygen, resulting in impaired 
cytochrome c oxidase activity and increase oxidative stress38. However, this possibility appeared unlikely, as we 
measured a low level of oxidative stress and observed an apparent mitochondrial membrane integrity in the SDS 
cells (Supplementary Figure 3).
Notably, even though complex IV has an indirect role in ROS production, it is possible that the impairment of 
complex IV may be caused by upstream electron accumulation at the level of complexes I and III, which causes 
increased ROS production. In fact, the mitochondrial electron transport chain contains several redox centres 
that may directly transfer an electron to oxygen, creating ROS39–43. However, there can be other structures that 
may be involved in oxidative stress induction. In particular, as SDS cells are characterized by a defect in protein 
biogenesis, it is possible that an accumulation of the defective proteins may contribute to the unfolded protein 
response in the endoplasmic reticulum44.
Another possible cause of the complex IV impairment could be related to the reported altered calcium level in 
SDS cells. Intracellular calcium homeostasis plays an important role in the regulation of the biochemical pathways 
that modulate the response to energetic stress. In particular, Ca2+ has a dual effect on energetic metabolism. One 
effect is that the [Ca2+]i enhances OXPHOS, which activates Krebs cycle dehydrogenases and mitochondrial sub-
strate transporters. The other effect is that it may affect complex IV activity by competing for its cation-binding 
site45.
Considering these data (Fig. 6), the high [Ca2+]i observed in SDS cells might be relevant to explain the bio-
chemical phenotype of SDS cells. SBDS cooperates with elongation factor-like 1 (EFL1) for the release of eIF6 
from the pre-60S ribosomal subunit, allowing for the formation of ribosome 80S5,46. In SDS cells, maturation of 
the 60S subunit is, therefore, defective and its association with the 40S subunit impaired. Moreover, the binding 
of eIF6 to the pre-60S subunit persists even in the cytoplasm, preventing its recycling to nucleolus47. Considering 
that the nuclear import of eIF6 is modulated by intracellular Ca2+ 48, we could speculate that the increased cyto-
plasmic calcium concentration in SDS cells attempts to balance the defective ribosome biogenesis.
Energetic stress induces changes in cellular metabolism that stimulate or inhibit a network of molecules 
involved in the regulation of energetic balance, such as AMPK and mTOR49,50. In the observed SDS cells, as 
Figure 5. Leucine induced increased erythroid cell colonies and regulated the energetic stress biochemical 
pathway. (A) A clonogenic assay on the SDS MNCs showed increased erythroid colonies after treatment with 
leucine (closed circles); however, no myeloid colony induced effect was observed (open circles). (B) The AMPK, 
mTOR and AKT (Thr803 and Ser473) phosphorylation levels in SDS cells was reduced after leucine treatment 
and were similar to wt cell levels and was representative of respiratory and energetic stress recovery after leucine 
treatment. (C). Densitometric analysis of the WB signals. The data are expressed as relative optical densities.
www.nature.com/scientificreports/
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a consequence of the energetic stress, AMPK was hyperactivated and the glycolytic pathway was stimulated. 
Surprisingly, we also found that the AKT/mTOR pathway was aberrantly hyper activated, as both of these proteins 
were hyper-phosphorylated. We speculate that mTOR hyper activation is a way through which SDS cells support 
the energy defect and protein synthesis, in an attempt to improve the OXPHOS activity. However, treatment of 
SDS cells with the mTOR antagonist, rapamycin, totally inhibited the residual OXPHOS activity, which led to 
decreased ROS production and a consequent energy recovery by glycolysis (data not shown). This suggests that 
in the altered biochemistry of the SDS cells, the increase in OXPHOS activity, which guarantees an increase in 
ATP production, may at the same time lead to the enhancement of the oxidative stress and a potential increase in 
cell damage (Fig. 6). Another potential mechanism responsible of mTOR activation in presence of an activated 
AMPK could be linked to autophagy activation. In ribosomopathies, increased oxidative stress induces autophagy 
through an mTOR-S6 kinase pathway51. Considering the data reported in this manuscript, we can hypothesize 
that the AMPK enhanced activity could be related to an impairment in the cellular energetic status, while the 
mTOR pathway activation might be related to a high level of oxidative stress production.
Moreover, mTOR also controls several Ca2+ -dependent processes. For example, it positively regulates IP3R 
(inositol tri-phosphate receptor)-mediated Ca2+ release33 and, in association with Akt, it participates in the reg-
ulation of mitochondrial associated endoplasmic reticulum membrane (MAM) integrity, calcium flux and ener-
getic metabolism52.
Finally, an increase in glycolytic metabolism induces the accumulation of lactic acid and a decrease in the 
intracellular pH, resulting in the inhibition of the calcium pumps and subsequently in an increase in cytosolic 
[Ca2+]53 (Fig. 6).
Leucine is an essential amino acid that induces cell proliferation and protein synthesis. Ribosomopathies, such 
as Blackfan Diamond Anaemia and del(5q) MDS, or other pathologies with ribosomal biogenesis defects, such 
as Cornelia de Lange or Roberts syndrome, benefit from treatment with this amino acid18,54–56. Consistent with 
these studies, we found that leucine improved in vitro erythropoiesis from SDS individuals. Moreover, treatment 
of SDS cells with leucine restored OXPHOS and ATP synthesis, reduced the cytoplasmic calcium concentra-
tion and the AMPK and AKT/mTOR activity, which point to leucine as a potentially helpful tool in sustaining 
the deranged energetic metabolism and erythropoiesis of SDS patients. In particular, considering that leucine 
improves OXPHOS activity, partially restoring respiration, it may act as a modulator of both the AMPK and 
AKT/mTOR pathways by restoring their physiological roles. We can speculate that the decreased oxidative stress 
induced by leucine leads to a consequent inactivation of mTOR - S6 kinase pathway51.
Finally, it is interesting to note that energetic metabolism is a determinant for the maintenance of self-renewing 
stem cells. Haematopoietic stem cells (HSC) in the bone marrow are sequestered in a hypoxic microenviron-
ment57. Hypoxic conditions maintain HSCs in a quiescent state, which is associated with glycolytic metabolism. 
During (asymmetric) self-renewal stem cell division, one cell maintains the characteristic of a stem cell with 
glycolytic metabolism, while the other cell moves into the blood vessels and acquires OXPHOS metabolism and 
differentiates. Haematopoietic stem cells are sensitive to increased oxidative stress and mitochondrial oxidative 
phosphorylation is the main cause of ROS. Glycolytic metabolism is therefore a determinant of the self-renewing 
maintenance of HSCs. To reduce mitochondrial metabolism, HSCs positively regulate AMPK while repress-
ing the PI3K/mTOR pathway. Constitutively active AKT or mTOR signalling58 and high [Ca2+]i levels59 cause 
increased proliferation and HSC impoverishment. Hence, this work may provide a new perspective in the under-
standing of the biochemical pathways that lead to bone marrow failure in SDS patients.
In conclusion, we report for the first time that SDS cells suffer from energetic stress and severe respira-
tory defects related to the faulty SBSD protein, even though SDS cells do not display a significant alteration in 
Figure 6. Representative scheme of the biochemical alterations in SDS cells. (A) The scheme represents 
possible interconnections among the several aspects considered in this study (see Discussion). (B) The scheme 
focuses attention on the biochemical pathways involved in the energetic status of the cell. In particular, it 
is possible to hypothesize that the impairment of Complex IV may be a reason for the decreased energy 
production and increased oxidative stress. The loss of ATP synthesis may activate the AMPK pathway, inducing 
an increase in the glycolysis pathway to support the cell energy demands. Moreover, the mTOR pathway also 
seemed to be activated, probably to improve the energy production in the mitochondria. However, in the SDS 
cell, these reactions led to a vicious circle, which could increase the ATP/AMP ratio impairment.
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mitochondrial morphology. These defects are partially compensated by enhanced AMPK, glycolysis and mTOR/
Akt pathway activation. A pivotal role in the maintenance of this altered metabolism could be because of altered 
calcium homeostasis.
Materials and Methods
Cell culture and treatments. Cells were obtained from the “Cell Line and DNA Biobank from Patients 
affected by Genetic Diseases” (G. Gaslini Institute) - Telethon Genetic Biobank Network (Project No. 
GTB07001)60. Study approval was obtained from the Institutional Review Board of all participating centres. For 
studies on cells and cell lines, written informed consent was obtained from patients or from relatives/guardians 
whenever applicable. All experiments were carried out in accordance with the approved guidelines.
SDS and wild type lymphoblast cell lines were grown at 37 °C in RPMI supplemented with 10% foetal calf 
serum and antibiotics. Primary lymphocytes were isolated from the PB by Ficoll gradient centrifugation and grown 
at 37 °C in RPMI supplemented with 10% foetal calf serum, antibiotics and phytohaemagglutinin (20 μ g/ml). 
Leucine (600 μ g/ml) was added to the cells once a day for five days. One hour after the last treatment, the cells 
were harvested and used for protein extracts or biochemical experiments. Thapsigargin (TG, 3 μ M) was added 
directly to the cells in PBS buffer.
SDS corrected cell lines. cDNA from wild-type cells was used with standard PCR to amplify the SBDS gene 
for 30 cycles with the following primers: sense 5′ -taagatggaacaaaaactcatctcagaagaggatctgatgtcgatcttcacccccac-3′, 
anti-sense 5′ -TTGATGGGTGTCATTCAAATTTCTCATCTC-3′ . An N-terminal Myc Tag was introduced in 
the PCR product (sequence underlined in 5′ primer). Myc-SBDS was cloned with the TOPO® TA cloning vector 
system I (Invitrogen), and then subcloned into the KpnI/XhoI site of the pcDNA3.1 mammalian expression vec-
tor (Invitrogen). Identification of the recombinants was carried out by HindIII/BamHI endonuclease digestion 
and sequencing.
A corrected cell line was obtained by transfection of the SDS cell line with the pCDNA-Myc-SBDS vector. The 
transfection was carried out with lipofectamine following the manufacturer’s instruction.
The transfection efficiency was evaluated by Western blot analysis of the SBDS protein (Supplementary Figure 1).
Biochemical characterization of SDS cells was conducted on 4 lymphoblast and 4 lymphocyte cell lines. Two 
lymphoblast and 2 lymphocyte cell lines were used for leucine experiments, and 2 lymphoblast cell lines were 
used for genetic complementation.
Cell homogenate preparation. Cultured cells were centrifuged to remove the growth medium at 1,000 g 
for 2 min. The pellet was suspended in phosphate buffer saline (PBS), and sonicated 2 times for 10 seconds, with 
a break of 30 sec in ice. Total protein levels were estimated with the Bradford method.
ATP/AMP ratio evaluations. The ATP and AMP quantification was based on the enzyme coupling method 
by Bergmeyer et al.61. ATP was assayed, following NADP reduction at 340 nm. The medium contained 50 mM Tris 
HCl pH 8.0, 1 mM NADP, 10 mM MgCl2, and 5 mM glucose in 1 ml final volume. Samples were analysed spectro-
photometrically before and after the addition of 4 μ g of purified hexokinase/glucose-6-phosphate dehydrogenase. 
AMP was assayed following the NADH oxidation at 340 nm. The medium contained 50 μ g of cells homogen-
ate, 100 mM Tris-HCl (pH 8.0), 75 mM KCl, 5 mM MgCl2, 0,2 mM ATP, 0,5 mM phosphoenolpyruvate, 0,2 mM 
NADH, 10 IU adenylate kinase, 25 IU pyruvate kinase, and 15 IU of lactate dehydrogenase. Twenty micrograms 
of total protein was used for both assays.
Evaluation of oxygen consumption in Shwachman cells. Oxygen consumption was measured at 25 °C 
in a closed chamber with an amperometric electrode (Unisense-Microrespiration, Unisense A/S, Denmark)13. For 
each experiment, 500,000 cells were used. The cells were permeabilized with 0.3 mg/ml digitonin for 1 min. Ten 
millimolar pyruvate plus 5 mM malate was added to stimulate the complex I, III and IV pathways. Twenty milli-
molar succinate was added to stimulate the complex II, III and IV pathways. Rotenone (0.1 mM) or antimycin A 
(0.2 mM) were used as inhibitors for the first and second pathways, respectively. Rotenone is considered a specific 
inhibitor of complex I, the NADH-ubiquinone oxide reductase, because it blocks the transfer of electrons from 
iron-sulfur centres N2 to ubiquinone. This creates a back-up of electrons within the mitochondrial matrix62.
Antimycin A is an antibiotic that specifically inhibits complex III, cytochrome c reductase. It acts by blocking 
the transfer of electrons between Cyt bH and coenzyme Q that is bound at the QN site63.
Respiratory complex assay activity. For each assay, 20 μ g of total protein were used. The assays were 
performed spectrophotometrically, as previous reported64.
Extracellular lactate evaluation. The lactate concentration was assayed spectrophotometrically in the 
growth medium, following the reduction of NAD+ at 340 nm61. The assay medium contained 100 mM Tris HCl 
pH 8, 5 mM NAD+, 1 IU/ml of lactate dehydrogenase. Samples were analysed spectrophotometrically before and 
after the addition of 4 μ g of purified lactate dehydrogenase. The data were normalized by the cell number.
Cytometry and malondialdehyde evaluation in Shwachman cells. Stress induced by cell expo-
sure to H2O2 and ROS was quantified by flow cytometry measurements after staining cells with H2DCFDA 
(2′ ,7′ -dichlorodihydrofluorescein diacetate), according to Cuccarolo et al.29. To assess the lipid peroxidation in 
the Shwachman cells, the malondialdehyde (MDA) concentration was evaluated with the thiobarbituric acid 
reactive substances (TBARS) assay65 at 532 nm.
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Electron microscopy. For this analysis lymphocyte pellets from healthy donors and patients with SDS were 
employed. Study approval was obtained from the Institutional Review Board of all participating centres. For 
studies on cells and cell lines, written informed consent was obtained from patients or from relatives/guardians 
whenever applicable. All experiments were carried out in accordance with the approved guidelines.
Cell pellets were fixed with 2.5% glutaraldehyde/0.1 M cacodylate buffer at pH 7.6 for 1 h at room temperature. 
After post-fixation with 1% OsO4 in cacodylate buffer for 1 h, pellets were dehydrated in an ethanol series and 
embedded in Epon resin. Ultrathin sections stained with uranyl-acetate and lead citrate were observed with a Jeol 
Jem-1011 transmission electron microscope. Two hundred mitochondria were examined for each sample.
Western Blot. Denaturing electrophoresis (SDS–PAGE) was performed with a Laemmli protocol, with 
minor modifications, in a Mini Protean III (BioRad, Hercules, CA, USA) apparatus. Twenty micrograms of total 
protein was used for each sample. Electrophoretically separated samples was transferred onto nitrocellulose 
(NC) membranes by electroblotting at 400 mA for 1 h at 4 °C. The NC membranes were blocked in 5% bovine 
serum albumin (BSA) overnight, then washed in 0.15% phosphate buffered saline-tween (PBS-T) and incubated 
with specific antibodies (Abs) (overnight at 4 °C) against phospho-AMPKα (Thr172), AMPKα , phospho-AKT_
Ser473, phospho-AKT_Thr308, AKT, phospho-mTOR_Ser2448, mTOR, COX5A, COX2, ND4L, Actin and 
SBDS (all purchased from Cell Signalling). Secondary HPR-conjugated Abs were 1:10,000 diluted in PBS-T. Abs 
was revealed with an enhanced chemiluminescence detection system using ChemiDoc XRS (BioRad, Hercules, 
CA, USA). Densitometric analysis was performed with ChemiDoc XRS, and the density signals were comparing 
against actin, which was used as a housekeeping protein.
Ca2+ ATPase activity assay. Ca2+ ATPase activity was determined from cell homogenates at 25 °C using an 
enzyme-coupled spectrophotometric assay, in which ATP hydrolysis is coupled to NADH oxidation66.
Clonogenic assay. In vitro assays for erythroid colony- and burst-forming unit growth (CFU-Es and 
BFU-Es, respectively) were performed using methyl cellulose media (StemCell Technologies, Vancouver, Canada) 
complemented with cytokines, as described elsewhere67.
Cytosolic [Ca2+]i concentration calculations. Intracellular calcium 2+ concentrations [Ca2+]i were 
measured by using the ratiometric membrane-permeant fluorescent indicator dye, Fura2/AM (Invitrogen, 
Life Technologies, Italy). Cells grown on 20 mm coverslips were incubated with 10 μ M Fura2/AM in standard 
PBS buffer for 45 min at 37 °C and then washed at room temperature. The intracellular free Ca2+ concentration 
was calculated according to following equation: [Ca2+]i = β Kd(R − Rmin)/(Rmax − R) where R is E340/E380; Rmin is 
E340/E380 in zero Ca2+; Rmax is E340/E380 in the Ca2+ -saturated solution; β is E380 in the zero Ca2+/E380 in Ca2+ satu-
rated solution and Kd is the dissociation constant of the dye at room temperature (140 nM). To obtain the Rmin and 
Rmax values, the Ca2+ ionophore, ionomycin (2 nM), was added after each experiment in a zero-Ca2+ bath (0 Ca2+, 
2 mM EGTA) and then the cells were perfused with a saturating Ca2+ solution. At the end of this procedure, 5 mM 
MnCl2 was added to the bath to quench the fluorescence of the dye and to determine the background values.
Statistical analysis. Data were analysed with one-way ANOVA and unpaired two-tail Student’s t tests using 
the instat software (GraphPad Software, Inc., La Jolla, CA, USA). Data are expressed as means ± standard devi-
ation (SD) from 3 to 5 independent determinations performed in duplicate. In the figures, the SDs are shown as 
error bars. An error probability with P < 0.05 was selected as the significance level.
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